O07 Randomised, open labelled clinical trial to investigate synovial mechanisms determining response: resistance to rituximab versus tocilizumab in RA patients failing TNF inhibitor therapy
dc.contributor.author | Humby, FC | en_US |
dc.contributor.author | Lewis, M | en_US |
dc.contributor.author | Durez, P | en_US |
dc.contributor.author | Buch, MH | en_US |
dc.contributor.author | Bombardieri, M | en_US |
dc.contributor.author | Rizvi, H | en_US |
dc.contributor.author | Rivellese, F | en_US |
dc.contributor.author | Fossati, L | en_US |
dc.contributor.author | Hands, R | en_US |
dc.contributor.author | Giorli, G | en_US |
dc.contributor.author | John, C | en_US |
dc.contributor.author | Mahto, A | en_US |
dc.contributor.author | Kelly, S | en_US |
dc.contributor.author | Nerviani, A | en_US |
dc.contributor.author | Montecucco, C | en_US |
dc.contributor.author | Lauwerys, B | en_US |
dc.contributor.author | Ng, N | en_US |
dc.contributor.author | Thornborn, G | en_US |
dc.contributor.author | Romao, VC | en_US |
dc.contributor.author | Ho, P | en_US |
dc.contributor.author | Verschueren, P | en_US |
dc.contributor.author | Sainaghi, PP | en_US |
dc.contributor.author | Bellan, M | en_US |
dc.contributor.author | Bugatti, S | en_US |
dc.contributor.author | Pratt, AG | en_US |
dc.contributor.author | Holyroyd, C | en_US |
dc.contributor.author | Congia, M | en_US |
dc.contributor.author | Thompson, C | en_US |
dc.contributor.author | Gendi, N | en_US |
dc.contributor.author | Dasgupta, B | en_US |
dc.contributor.author | Cauli, A | en_US |
dc.contributor.author | Reynolds, P | en_US |
dc.contributor.author | Cañete, J | en_US |
dc.contributor.author | Moots, RJ | en_US |
dc.contributor.author | Taylor, PC | en_US |
dc.contributor.author | Edwards, C | en_US |
dc.contributor.author | Isaacs, J | en_US |
dc.contributor.author | Sasieni, P | en_US |
dc.contributor.author | Fonseca, JE | en_US |
dc.contributor.author | Choy, E | en_US |
dc.contributor.author | Pitzalis, C | en_US |
dc.date.accessioned | 2020-11-06T15:16:05Z | |
dc.date.issued | 2020-04-01 | en_US |
dc.identifier.issn | 1462-0324 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/68070 | |
dc.title | O07 Randomised, open labelled clinical trial to investigate synovial mechanisms determining response: resistance to rituximab versus tocilizumab in RA patients failing TNF inhibitor therapy | en_US |
dc.type | Conference Proceeding | |
dc.identifier.doi | 10.1093/rheumatology/keaa110.006 | en_US |
pubs.issue | Supplement_2 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 59 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |